KyungMann Kim

13PUBLICATIONS
100CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 06, 2025
Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial Cancer.

Britt K Erickson, Howard Bailey, Rebecca C Arend

|May 29, 2025
The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor Efficacy.

Caroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski

|Sep 18, 2024
Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade.

Justin C Jagodinsky, Jessica M Vera, Won Jong Jin

|Aug 27, 2024
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery.

Tracy M Downs, Howard H Bailey, Taja Lozar

|May 31, 2023
A Systematic Review and Pooled Analysis of Hypothesized versus Observed Effect Sizes in Early Phase Cancer Prevention Clinical Trials.

Jens Eickhoff, Jen Zaborek, Guanhua Chen

|Feb 24, 2023
Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial.

A S Feils, A K Erbe, J Birstler

Pageof 3

Frequent Collaborators

3 joint publications

Jen Zaborek

2 joint publications

Howard H Bailey

2 joint publications

Katina DeShong

2 joint publications

Eva Szabo